Founded
Address
Three Arch Partners
3200 Alpine Road
Portola Valley, CA 94028
United States
Phone
Email
Website
Recent investment activity
KANDO id: 32222
Company type
Venture capital firm focused on healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors.Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Three Arch Partners IV | Venture | 2004 | USD | 450,000,000 |
| Three Arch Capital | 2000 | USD | 300,000,000 | |
| Three Arch Partners III | Venture | 1999 | USD | 200,000,000 |
| Three Arch Partners II | Venture | 1997 | USD | 80,000,000 |
| Three Arch Partners I | Venture | 1994 | USD | 30,000,000 |
Funding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 1 - 25 of 85| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Nevro Corp | Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. | N/A | |||
|
|
Neuronetics Inc | Series E | ||||
|
|
Baxano Inc | A medical device company focused on developing minimally invasive tools to restore spine function and preserve healthy tissue. | Series C | |||
|
|
Hemosphere Inc | Developed a vascular access product that has the potential to significantly reduce the risk of bacteremia | Series A | |||
|
|
Calibra Medical Inc | A medical device company developing a unique, wearable three-day insulin patch. | N/A | |||
|
|
Neuronetics Inc | Series D | ||||
|
|
iScience Interventional Inc | Leading the discovery and development of the product platforms used in Interventional Ophthalmology | Series F | |||
|
|
Visiogen Inc | A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. | Series D Initial investment | |||
|
|
Arete Therapeutics Inc | A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. | Series A | |||
|
|
Cardiac Concepts Inc | Now known as Respicardia Inc | Series B | |||
|
|
APT Pharmaceuticals Inc | A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations. | Series A Initial investment | |||
|
|
Nevro Corp | Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. | Series A | |||
|
|
Calibra Medical Inc | A medical device company developing a unique, wearable three-day insulin patch. | Series B | |||
|
|
Concert Pharmaceuticals Inc | A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. | Series C | |||
|
|
Benvenue Medical Inc | Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. | Series B | |||
|
|
NeuroVista Corp | Series B | ||||
|
|
Reliant Technologies Inc | A medical device company that has developed and manufactured laser technology that stimulated the body to replace aged, photo-damaged skin. | Series E | |||
|
|
Calistoga Pharmaceuticals Inc | Biopharmaceutical company dedicated to developing targeted therapies to improve the health of patients with cancer or inflammatory diseases. | Series A | |||
|
|
Concert Pharmaceuticals Inc | A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. | Series B | |||
|
|
LipoScience Inc | Diagnostic company developing clinical applications of nuclear magnetic resonance (NMR) spectroscopy. | Series F | |||
|
|
Concert Pharmaceuticals Inc | A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. | Series A | |||
|
|
Sirtris Pharmaceuticals Inc | Series C | ||||
|
Allux Medical Inc | Medical device company developing medical devices for the treatment of hyper-reactive airway mucosa. | N/A Initial investment | |||
|
|
Confluent Surgical Inc | A medical device company leading in the field of surgical sealants and adhesion barriers for use in neurosurgery, gynecologic and general surgery. | Series D | |||
|
|
Sirtris Pharmaceuticals Inc | Series B |
Current team
Former team members
| Employee | Company | Position | |||
|---|---|---|---|---|---|
| Michael Kaplan | Littlejohn & Co LLC | [email protected] |